|
Our patented, breakthrough VasoWaveTM cardio emulator perfusion and transplant technology will enhance the quality/vitality of transplant organs and extend their transplant preservation time window. We are unlocking the doors to organ preservation and regeneration and expanding the donor pool.
|
As of May 31, 2008, more than 98,973 men, women, and children are on the U.S. organ transplant wait list. Of these 76,104 are waiting for kidneys. Only, 16,623 received a kidney transplant in 2007, and the waiting list donor gap is growing each year.
Our goal is to save the lives of thousands of Transplant Wait List patients each year and to reduce their overall lifetime health care costs, literally by billions of dollars. Dialysis is a debilitating and expensive temporary solution to end stage kidney failure. Transplants are the permanent solution, and our technology will help bridge the gap between kidney donors and recipients.
We are starting with the kidney, but we will be adapting our VasoWaveTM cardio emulator platform to address the liver, lung, heart, pancreas, and intestines.
|
Smart Perfusion LLC copyright 2007 - 2008
|
|